Mouth Cancer: A Comprehensive Analysis of Epidemiology, Etiology, and Innovations in Prevention and Treatment

Mouth cancer, a leading cause of cancer-related morbidity and mortality, remains a global health concern with an increasing incidence in both developed and developing nations. Despite advancements in diagnostic imaging, targeted therapies, and immunotherapy, the late-stage detection of oral cancer continues to contribute to poor survival rates. This paper examines the epidemiology, risk factors, and genetic influences associated with mouth cancer while critically analyzing current treatment approaches and emerging innovations, such as CRISPR-based gene therapy and AI-driven diagnostics. The role of HPV in oropharyngeal cancers is explored, emphasizing the need for gender-neutral HPV vaccination programs. Additionally, the paper debates the effectiveness of government policies on tobacco, alcohol, and betel quid regulation in mitigating the disease burden. The ethical challenges of high-cost cancer drugs, access disparities, and the balance between aggressive treatment and quality of life are discussed. This research advocates for global policy reforms, including integrated oral cancer screenings in routine healthcare visits, expanded access to affordable immunotherapy, and stronger public health campaigns aimed at high-risk populations. The findings underscore the need for multidisciplinary collaboration between oncologists, policymakers, and AI researchers to achieve equitable cancer care by 2030. Keywords Mouth cancer, oral cancer, HPV vaccination, tobacco control, AI in cancer diagnosis, CRISPR, immunotherapy, EGFR inhibitors, targeted therapy, cancer prevention, global health policies, gene therapy, early detection, epidemiology, public health intervention.